Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 9, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	60	18	14	14	15	98
Market Cap Growth	243.73%	22.07%	6.55%	-11.52%	-84.38%	26.45%
Enterprise Value	47.55	6.85	13.41	8.22	8.24	90.3
Last Close Price	7.14	2.47	4.45	4.41	6.44	51.66
PE Ratio	-	-	-	-	-1.18	-7.31
Forward PE	-	-	-	-	56.67	-
PS Ratio	-	22.50	20.70	23.34	19.65	9.49
PB Ratio	12.78	1.42	7.29	1.92	1.63	7.51
P/TBV Ratio	-	-	-	-	1.58	6.88
P/FCF Ratio	-	-2.41	-2.96	-2.04	-1.25	-7.18
P/OCF Ratio	-	-2.41	-2.96	-2.04	-1.25	-7.18
EV/Sales Ratio	-	8.74	19.21	14.15	10.56	8.73
EV/EBITDA Ratio	-	-0.88	-1.96	-0.91	-0.45	-3.83
EV/EBIT Ratio	-	-0.87	-1.91	-0.89	-0.45	-3.81
EV/FCF Ratio	-	-0.94	-2.74	-1.24	-0.67	-6.61
Debt / Equity Ratio	-	0	0	0.00	0	0.00
Debt / EBITDA Ratio	-	-	0.00	-0.01	0.00	0.00
Debt / FCF Ratio	-	-	0.00	-0.01	0.00	-0.01
Net Debt / Equity Ratio	-0.86	-0.87	-0.51	-0.75	-0.75	-0.59
Net Debt / EBITDA Ratio	1.46	1.39	0.15	0.58	0.39	0.33
Net Debt / FCF Ratio	1.53	1.47	0.21	0.79	0.58	0.57
Asset Turnover	0.06	0.09	0.11	0.06	0.06	0.82
Quick Ratio	16.51	10.60	0.71	3.29	3.90	7.64
Current Ratio	16.82	10.67	0.91	3.53	4.25	8.29
Return on Equity (ROE)	-96.38%	-99.57%	-136.66%	-101.88%	-156.34%	-120.39%
Return on Assets (ROA)	-88.54%	-91.24%	-110.44%	-90.14%	-140.45%	-186.87%
Return on Invested Capital (ROIC)	-641.99%	-603.20%	-511.05%	-445.06%	-475.42%	-635.43%
Return on Capital Employed (ROCE)	-103.02%	-109.63%	-155.03%	-111.77%	-162.85%	-211.83%
Earnings Yield	-13.11%	0.00%	0.00%	0.00%	-84.78%	-13.69%
FCF Yield	-13.24%	-41.51%	-33.84%	-48.93%	-80.14%	-13.93%
Buyback Yield / Dilution	-64.03%	-43.75%	-5.05%	-37.72%	-78.01%	-14.64%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q